Cargando…
Variable Na(v)1.5 Protein Expression from the Wild-Type Allele Correlates with the Penetrance of Cardiac Conduction Disease in the Scn5a (+/−) Mouse Model
BACKGROUND: Loss-of-function mutations in SCN5A, the gene encoding Na(v)1.5 Na(+) channel, are associated with inherited cardiac conduction defects and Brugada syndrome, which both exhibit variable phenotypic penetrance of conduction defects. We investigated the mechanisms of this heterogeneity in a...
Autores principales: | , , , , , , , , , , , , , , , , , |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2824822/ https://www.ncbi.nlm.nih.gov/pubmed/20174578 http://dx.doi.org/10.1371/journal.pone.0009298 |
Sumario: | BACKGROUND: Loss-of-function mutations in SCN5A, the gene encoding Na(v)1.5 Na(+) channel, are associated with inherited cardiac conduction defects and Brugada syndrome, which both exhibit variable phenotypic penetrance of conduction defects. We investigated the mechanisms of this heterogeneity in a mouse model with heterozygous targeted disruption of Scn5a (Scn5a (+/−) mice) and compared our results to those obtained in patients with loss-of-function mutations in SCN5A. METHODOLOGY/PRINCIPAL FINDINGS: Based on ECG, 10-week-old Scn5a (+/−) mice were divided into 2 subgroups, one displaying severe ventricular conduction defects (QRS interval>18 ms) and one a mild phenotype (QRS≤18 ms; QRS in wild-type littermates: 10–18 ms). Phenotypic difference persisted with aging. At 10 weeks, the Na(+) channel blocker ajmaline prolonged QRS interval similarly in both groups of Scn5a (+/−) mice. In contrast, in old mice (>53 weeks), ajmaline effect was larger in the severely affected subgroup. These data matched the clinical observations on patients with SCN5A loss-of-function mutations with either severe or mild conduction defects. Ventricular tachycardia developed in 5/10 old severely affected Scn5a (+/−) mice but not in mildly affected ones. Correspondingly, symptomatic SCN5A–mutated Brugada patients had more severe conduction defects than asymptomatic patients. Old severely affected Scn5a (+/−) mice but not mildly affected ones showed extensive cardiac fibrosis. Mildly affected Scn5a (+/−) mice had similar Na(v)1.5 mRNA but higher Na(v)1.5 protein expression, and moderately larger I(Na) current than severely affected Scn5a (+/−) mice. As a consequence, action potential upstroke velocity was more decreased in severely affected Scn5a (+/−) mice than in mildly affected ones. CONCLUSIONS: Scn5a (+/−) mice show similar phenotypic heterogeneity as SCN5A-mutated patients. In Scn5a (+/−) mice, phenotype severity correlates with wild-type Na(v)1.5 protein expression. |
---|